Other Therapeutic Areas

In addition to rheumatoid arthritis, Dendright’s tolerizing immunotherapy platform technology is applicable to the following autoimmune disease indications:

  • Type 1 diabetes
  • Celiac disease
  • Haemophilia
  • Multiple sclerosis
  • Thyroiditis

The platform technology may also be applicable to symptoms associated with allergy, transplantation and graft rejection.